The compound is not a supplement, cosmetic or therapeutic substance and any misuse outside of research applications is against regulatory guidelines and institutional policies
Data availability The atomic coordinates and electron microscopy maps have been deposited in the Protein Data Bank (PDB) and Electron Microscopy Data Bank (EMDB) under accession codes: 9BP3/EMD-44760 [ (Cagri-AMY 1 R-DNG s complex), 9BLW/EMD-44678 [ (CagriBB-AMY 1 R-DNG s complex), 9BQ3/EMD-44796 [ (Cagri-AMY 2 R-DNG s complex), 9BTW]/EMD-44898 [ (Cagri-AMY 3 R-DNG s complex), 9BUB/EMD-44904 [ (Cagri-CTR-DNG s complex 1, bypass conformation), 9BUD/EMD-44906 [ (Cagri-CTR-DNG s complex 1, CT-like conformation), 9BUC/EMD-44905 [ (Cagri-CTR-DNG s complex 2, bypass conformation), 9BUE/EMD-44907 [ (Cagri-CTR-DNG s complex 2, CT-like conformation), 9BLC/EMD-44653 [ (CagriBB-CTR-DNG s complex 1, CT-like conformation), 9BLB/EMD-44652 [ (CagriBB-CTR-DNG s complex 1, bypass conformation)
Component validation : CagriSema benefits from each component (semaglutide, cagrilintide) having independent extensive clinical data
This non-invasive treatment reduces inflammation, improves circulation, and accelerates tissue repair without causing discomfort
Its mechanism of action involves promoting the development of new blood vessels (angiogenesis) and facilitating the migration of stem cells to damaged areas, which can accelerate tissue recovery